Our Approach to Human Practices
From the start of our project, we grounded each stage of our work in integrated human practices. Before advancing development, we actively sought input from key stakeholders who could provide valuable insight into factors that needed to be considered. This included collaborations with industry partners, public health experts, university laboratories, and educational communities. Each interaction centered around open-ended discussions about the potential impact and implications of our project. The feedback we received guided our decision-making, confirming some directions while prompting us to reevaluate and rethink others. These dialogues also allowed us to gain a nuanced understanding of the priorities and challenges faced by each stakeholder group: the economic and logistical pressures experienced by processors, the regulatory landscapes navigated by quality assurance teams, the clinical and epidemiological realities emphasized by public health researchers, and the communication and trust barriers uncovered through educational outreach.
Integrating human practices meant being willing to pivot. It is important to refine our design not just around theoretical goals, but around the actual needs of the communities and industries affected by Aflatoxin B1 contamination. This willingness to pivot transformed our project from a conceptual idea into a practical solution, ensuring that every design decision was informed by real-world feedback and grounded in social relevance. Through this depth of engagement, safeTEA evolved into a project that is not only scientifically innovative, but also socially responsive, community-centered, and feasible to implement in the real world.
Our educational outreach engaged diverse audiences to create bidirectional learning experiences that both refined safeTEA’s accessibility messaging and inspired the next generation of scientists to pursue careers in synthetic biology and bioengineering.